Page Header
Downloads:
0
Review of the Member State mechanism on substandard/spurious/falsely-labelled/falsified/counterfeit medical products
Overview
In 2012, the Sixty-fifth World Health Assembly adopted resolution WHA65.19, in which it decided to establish a Member State mechanism aimed at protecting public health and promoting access to affordable, safe, efficacious, and quality medical products, by promoting the prevention and control of substandard/spurious/falsely-labelled/falsified/counterfeit (SSFFC) medical products and associated activities. This resolution renewed and re-established a mandate for the Secretariat and Member States in addressing SSFFC medical products from a public health perspective in a transparent and inclusive way. The Member State mechanism is supported by WHO and facilitated by the mechanism secretariat.
A review of the Member State mechanism was mandated by the above resolution and conducted by the WHO Evaluation Office.
Report Details
| Year Published | |
| Type | |
| Theme/s | |
| Joint | No |
| Partner/s | N/A |
| SDG/s | |
| Consultant name | WHO Evaluation Office |
| Agency Focal Point | Dr Elil Renganathan |
| Focal Point Email | evaluation@who.int |
| Managed by Independent Evaluation Office | Yes |
Share:
Related
Member Publication
Downloads:
0
Member Publication
Downloads:
0
Member Publication
Downloads:
0
Member Publication
Downloads:
0
Member Publication
Downloads:
0
Member Publication
Downloads:
0
YOU 'RE READING
Review of the Member State mechanism on substandard/spurious/falsely-labelled/falsified/counterfeit medical products
